Search NASA⌕ Search

Engineering topics

Weber, Andrew

Publications and source records attributed to Weber, Andrew.

3 records
All sourcesNASA NTRSDOE OSTI
DOE OSTI2021

Critical steps in preventing future pandemics. Early lessons from the Covid-19 crisis for addressing natural and deliberate biological threats.

This report summarizes a virtual workshop on early lessons from the COVID-19 pandemic as they pertain to proactively addressing future biological threats. Co-hosted by Sandia National Laboratory (Sandia) and the Council on Strategic Risks (CSR) in August 2020, the discussion involved experts who at that time were leading innovative efforts in various U.S. government agencies, industry, and academia sharing observations from their ongoing pandemic response efforts. Based on the input by these expert participants, it is clear that even though the pandemic response is ongoing, the following recommendations will be important to consider for more successfully addressing biological threats in the future: Continue building on the cross-sector collaboration and agility shown in the COVID-19 response; Expand capabilities for detecting biological threats early; Prioritize ways to create and disseminate medical countermeasures even faster; Create the U.S. bio industrial base needed for rapid response to biological threats, and keep it healthy; and, Major government reorganization may not be needed if there is effective work to form coalitions, improve coordination, and expand steady-state and surge capacities.

29 ENERGY PLANNING, POLICY, AND ECONOMY↗
DOE OSTI2020

Detection of a multi–disease biomarker in saliva with graphene field effect transistors

Human carbonic anhydrase 1 (CA1) has been suggested as a biomarker for identification of several diseases including cancers, pancreatitis, diabetes, and Sjogren’s syndrome. However, the lack of a rapid, cheap, accurate, and easy-to-use quantification technique has prevented widespread utilization of CA1 for practical clinical applications. To this end, we present a label-free electronic biosensor for detection of CA1 utilizing highly sensitive graphene field effect transistors (G-FETs) as a transducer and specific RNA aptamers as a probe. The binding of CA1 with aptamers resulted in a positive shift in Dirac voltage V D of the G-FETs, the magnitude of which depended on target concentration. These aptameric G-FET biosensors showed the binding affinity (K D ) of ~2.3 ng/ml (70 pM), which is four orders lower than that reported using a gel shift assay. This lower value of K D enabled us to achieve a detection range (10 pg/ml - 100 ng/ml) which is well in line with the clinically relevant range. These highly sensitive devices allowed us to further prove their clinical relevance by successfully detecting the presence of CA1 in human saliva samples. In conclusion, the utilization of this label-free biosensor could facilitate the early stage identification of various diseases associated with changes in concentration of CAs.

77 NANOSCIENCE AND NANOTECHNOLOGY↗